Brought to you by:
Special VAM session underscores ‘complementary’ nature of open and endovascular strategies in CLTI patients
A dedicated session at VAM 2023 saw speakers and delegates gather to debate, analyse and consider the implementation of the BEST-CLI and BASIL-2 randomized-controlled trials (RCTs). There was general agreement that the strategies are complementary, and that “picking the right…
Presidential address: ‘The annual meeting is only part of our story’
Friday morning will see Michael C. Dalsing, MD, MBA, deliver what is an annual hallmark of the VAM program—the SVS Presidential Address. From 11:00 a.m.–12:15 p.m. in Potomac A/B, Dalsing will chart his personal journey from “small-town boy with some…
Carotid revascularization capable of improving mood in depressed patients with carotid atherosclerosis
A prospective study has demonstrated that carotid intervention can improve mood in depressed patients with advanced carotid disease, in addition to enabling cognitive improvements irrespective of baseline depression. These findings were presented during the Plenary Session 1: William J. von…
The global burden of CLTI: ESVS President points toward need for new global vascular guidelines
Early-bird VAM 2023 attendees yesterday gained broad insight into the issues facing vascular surgeons around the world, with the tone set from the opening talk on the World Federation of Vascular Societies (WFVS) Educational Session docket. Looking at the global…
Cross-specialty approach to embolization ‘provides the best care for patients’
Shang Loh, MD, is chief of vascular surgery and endovascular therapy at Penn Presbyterian Medical Center in Philadelphia and professor of clinical surgery at the University of Pennsylvania. Ahead of the Embolization for Vascular Surgeons: Techniques, Tips and Tricks lunch…
Learn the who, the when and the what of treating deep vein thrombosis
Between additional available therapies, multiple new devices now on the market and evolving research supporting thrombus removal, Patrick Muck, MD, and Madhavi Meka, MD, anticipated an informative session on deep vein thrombosis (DVT) at lunchtime Wednesday. The two surgeons co-moderated…
VAM 2023: Vascular Quality Initiative launches national smoking cessation drive
The SVS Patient Safety Organization (SVS PSO) has launched a national smoking cessation initiative. SVS PSO Associate Medical Director Gary Lemmon, MD, and SVS PSO Director of Quality Betsy Wymer introduced the program during SVS PSO’s Vascular Quality Initiative’s (VQI)…
Risk assessment models “no better than coin toss” for predicting bleeding in patients considered for VTE pharmacologic prophylaxis
A study of two risk assessment models (RAMs) for predicting the bleeding risk in patients considered for pharmacologic prophylaxis to prevent venous thromboembolism (VTE) has found that though an increasing risk score correlated with higher bleeding rates, both models had…
Opening ceremony heralds ‘power’ of VAM attendance
SVS President Michael Dalsing, MD, officially opened the 2023 Vascular Annual Meeting (VAM) yesterday morning, telling attendees at the early morning Opening Ceremony: “For 76 years, vascular surgeons have been developing and integrating ideas, tenacity and collaboration across this meeting—…
VAM 2023: Vascular trauma session to highlight the current role of endovascular therapy
A focused session on vascular trauma yesterday took a deep dive into emerging issues and controversies in the field. Moderated by Sherene Shalhub, MD, of Oregon Health & Science University, Portland, Oregon, and Rishi Kundi, MD, of the R Adams…